Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangwei Li

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemopreventionAnil K Gupta, James Pedroarena, Armen Nazarian, et al.
Journal of Medicinal Chemistry|March 3, 2026
Discovery of mCMV280: An Oral Ectoparasiticide in the Isoxazoline Class with Reduced Mammalian Brain ExposureSarah E McComic, Katy B Wilson, Zhilin Li, et al.
Cell|January 27, 2018
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific InhibitorMatthew R Janes, Jingchuan Zhang, Lian-Sheng Li, et al.
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry|June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemopreventionAnil K Gupta, James Pedroarena, Armen Nazarian, et al.
Journal of Medicinal Chemistry|March 3, 2026
Discovery of mCMV280: An Oral Ectoparasiticide in the Isoxazoline Class with Reduced Mammalian Brain ExposureSarah E McComic, Katy B Wilson, Zhilin Li, et al.
Cell|January 27, 2018
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific InhibitorMatthew R Janes, Jingchuan Zhang, Lian-Sheng Li, et al.
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry|June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 3